Pharmacological characterization of a new class of nonpeptide neurokinin A antagonists that demonstrate species selectivity

D. Aharony, C. K. Buckner, J. L. Ellis, S. V. Ghanekar, A. Graham, J. S. Kays, J. Little, Sonya Meeker, S. C. Miller, Bradley J Undem, I. R. Waldron

Research output: Contribution to journalArticle

Abstract

We examined the pharmacology of ZM253,270 and two representative examples of the pyrrolopyrimidines, a new class of nonpeptide, NK-2 receptor (NK-2R) antagonists. ZM253,270 competitively inhibited [3H]NKA binding to native or cloned NK-2R from hamster urinary bladder (K(i) = 2 nM), but was a weaker (48-fold) inhibitor of [3H]NKA binding to cloned human NK-2R. A similar species selectivity was observed with less potent analogs of ZM253,270. The pyrrolopyrimidines demonstrated only marginal inhibition of [3H]SP binding to NK-1R in guinea pig lung membranes (K(i) > 2 μM). In hamster trachea, ZM253,270 competitively antagonized the contractile response evoked by neurokinin A (NKA, -logK(B) = 7.5). In human bronchus, ZM253,270 was about 90-fold less potent as a competitive antagonist of NKA. The data from ligand binding assays in cloned receptors combined with functional receptor assays in airway smooth muscles, demonstrate that the nonpeptide antagonist ZM253,270 is selective for the NK2 receptor species that are prevalent in hamster, compared with those found in human tissues.

Original languageEnglish (US)
Pages (from-to)1216-1221
Number of pages6
JournalJournal of Pharmacology and Experimental Therapeutics
Volume274
Issue number3
StatePublished - 1995
Externally publishedYes

Fingerprint

Neurokinin A
Neurokinin-2 Receptors
Pharmacology
Cricetinae
Bronchi
Trachea
Smooth Muscle
ZM 253270
Guinea Pigs
Urinary Bladder
Ligands
Lung
Membranes

ASJC Scopus subject areas

  • Pharmacology

Cite this

Aharony, D., Buckner, C. K., Ellis, J. L., Ghanekar, S. V., Graham, A., Kays, J. S., ... Waldron, I. R. (1995). Pharmacological characterization of a new class of nonpeptide neurokinin A antagonists that demonstrate species selectivity. Journal of Pharmacology and Experimental Therapeutics, 274(3), 1216-1221.

Pharmacological characterization of a new class of nonpeptide neurokinin A antagonists that demonstrate species selectivity. / Aharony, D.; Buckner, C. K.; Ellis, J. L.; Ghanekar, S. V.; Graham, A.; Kays, J. S.; Little, J.; Meeker, Sonya; Miller, S. C.; Undem, Bradley J; Waldron, I. R.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 274, No. 3, 1995, p. 1216-1221.

Research output: Contribution to journalArticle

Aharony, D, Buckner, CK, Ellis, JL, Ghanekar, SV, Graham, A, Kays, JS, Little, J, Meeker, S, Miller, SC, Undem, BJ & Waldron, IR 1995, 'Pharmacological characterization of a new class of nonpeptide neurokinin A antagonists that demonstrate species selectivity', Journal of Pharmacology and Experimental Therapeutics, vol. 274, no. 3, pp. 1216-1221.
Aharony, D. ; Buckner, C. K. ; Ellis, J. L. ; Ghanekar, S. V. ; Graham, A. ; Kays, J. S. ; Little, J. ; Meeker, Sonya ; Miller, S. C. ; Undem, Bradley J ; Waldron, I. R. / Pharmacological characterization of a new class of nonpeptide neurokinin A antagonists that demonstrate species selectivity. In: Journal of Pharmacology and Experimental Therapeutics. 1995 ; Vol. 274, No. 3. pp. 1216-1221.
@article{117873699d804b459d68d151b3fc9258,
title = "Pharmacological characterization of a new class of nonpeptide neurokinin A antagonists that demonstrate species selectivity",
abstract = "We examined the pharmacology of ZM253,270 and two representative examples of the pyrrolopyrimidines, a new class of nonpeptide, NK-2 receptor (NK-2R) antagonists. ZM253,270 competitively inhibited [3H]NKA binding to native or cloned NK-2R from hamster urinary bladder (K(i) = 2 nM), but was a weaker (48-fold) inhibitor of [3H]NKA binding to cloned human NK-2R. A similar species selectivity was observed with less potent analogs of ZM253,270. The pyrrolopyrimidines demonstrated only marginal inhibition of [3H]SP binding to NK-1R in guinea pig lung membranes (K(i) > 2 μM). In hamster trachea, ZM253,270 competitively antagonized the contractile response evoked by neurokinin A (NKA, -logK(B) = 7.5). In human bronchus, ZM253,270 was about 90-fold less potent as a competitive antagonist of NKA. The data from ligand binding assays in cloned receptors combined with functional receptor assays in airway smooth muscles, demonstrate that the nonpeptide antagonist ZM253,270 is selective for the NK2 receptor species that are prevalent in hamster, compared with those found in human tissues.",
author = "D. Aharony and Buckner, {C. K.} and Ellis, {J. L.} and Ghanekar, {S. V.} and A. Graham and Kays, {J. S.} and J. Little and Sonya Meeker and Miller, {S. C.} and Undem, {Bradley J} and Waldron, {I. R.}",
year = "1995",
language = "English (US)",
volume = "274",
pages = "1216--1221",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Pharmacological characterization of a new class of nonpeptide neurokinin A antagonists that demonstrate species selectivity

AU - Aharony, D.

AU - Buckner, C. K.

AU - Ellis, J. L.

AU - Ghanekar, S. V.

AU - Graham, A.

AU - Kays, J. S.

AU - Little, J.

AU - Meeker, Sonya

AU - Miller, S. C.

AU - Undem, Bradley J

AU - Waldron, I. R.

PY - 1995

Y1 - 1995

N2 - We examined the pharmacology of ZM253,270 and two representative examples of the pyrrolopyrimidines, a new class of nonpeptide, NK-2 receptor (NK-2R) antagonists. ZM253,270 competitively inhibited [3H]NKA binding to native or cloned NK-2R from hamster urinary bladder (K(i) = 2 nM), but was a weaker (48-fold) inhibitor of [3H]NKA binding to cloned human NK-2R. A similar species selectivity was observed with less potent analogs of ZM253,270. The pyrrolopyrimidines demonstrated only marginal inhibition of [3H]SP binding to NK-1R in guinea pig lung membranes (K(i) > 2 μM). In hamster trachea, ZM253,270 competitively antagonized the contractile response evoked by neurokinin A (NKA, -logK(B) = 7.5). In human bronchus, ZM253,270 was about 90-fold less potent as a competitive antagonist of NKA. The data from ligand binding assays in cloned receptors combined with functional receptor assays in airway smooth muscles, demonstrate that the nonpeptide antagonist ZM253,270 is selective for the NK2 receptor species that are prevalent in hamster, compared with those found in human tissues.

AB - We examined the pharmacology of ZM253,270 and two representative examples of the pyrrolopyrimidines, a new class of nonpeptide, NK-2 receptor (NK-2R) antagonists. ZM253,270 competitively inhibited [3H]NKA binding to native or cloned NK-2R from hamster urinary bladder (K(i) = 2 nM), but was a weaker (48-fold) inhibitor of [3H]NKA binding to cloned human NK-2R. A similar species selectivity was observed with less potent analogs of ZM253,270. The pyrrolopyrimidines demonstrated only marginal inhibition of [3H]SP binding to NK-1R in guinea pig lung membranes (K(i) > 2 μM). In hamster trachea, ZM253,270 competitively antagonized the contractile response evoked by neurokinin A (NKA, -logK(B) = 7.5). In human bronchus, ZM253,270 was about 90-fold less potent as a competitive antagonist of NKA. The data from ligand binding assays in cloned receptors combined with functional receptor assays in airway smooth muscles, demonstrate that the nonpeptide antagonist ZM253,270 is selective for the NK2 receptor species that are prevalent in hamster, compared with those found in human tissues.

UR - http://www.scopus.com/inward/record.url?scp=0029037956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029037956&partnerID=8YFLogxK

M3 - Article

C2 - 7562491

AN - SCOPUS:0029037956

VL - 274

SP - 1216

EP - 1221

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -